Deep Brain Stimulation Impact on Voice and Speech Quality in Parkinson's Disease: A Systematic Review.
Parkinson's disease
deep brain stimulation
dysarthria
speech performance
voice
Journal
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
23
03
2022
accepted:
06
07
2022
pubmed:
31
8
2022
medline:
23
3
2023
entrez:
30
8
2022
Statut:
ppublish
Résumé
Deep brain stimulation (DBS) has considerable efficacy for the motor dysfunction of idiopathic Parkinson's disease (PD) on patient quality of life. However, the benefit of DBS on voice and speech quality remains controversial. We carried out a systematic review to understand the influence of DBS on parkinsonian dysphonia and dysarthria. A PubMed/MEDLINE and Cochrane systematic review was carried out following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Population, Intervention, Comparison, Outcome, Timing, and Setting (PICOTS) statements. Three investigators screened studies published in the literature from inception to May 2022. The following data were retrieved: age, demographic, sex, disease duration, DBS duration, DBS location, speech, and voice quality measurements. From the 180 studies identified, 44 publications met the inclusion criteria, accounting for 866 patients. Twenty-nine studies focused on voice/speech quality in subthalamic DBS patients, and 6 included patients with stimulation of pallidal, thalamic, and zona incerta regions. Most studies (4/6) reported a deterioration of the vocal parameters on subjective voice quality evaluation. For speech, the findings were more contrasted. There was an important heterogeneity between studies regarding the voice and speech quality outcomes used to evaluate the impact of DBS on voice/speech quality. The impact of DBS on voice and speech quality significantly varies between studies. The stimulated anatomical region may have a significant role since the stimulation of the pallidal area was mainly associated with voice quality improvement, in contrast with other regions. Future controlled studies comparing all region stimulation are needed to get reliable findings. Level III: evidence from evidence summaries developed from systematic reviews.
Identifiants
pubmed: 36040825
doi: 10.1177/01945998221120189
doi:
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
307-318Informations de copyright
© 2022 American Academy of Otolaryngology-Head and Neck Surgery Foundation.
Références
Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013.
Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015;386(9996):896-912.
Iranzo A. REM sleep behavior disorder, a parasomnia that predicts Parkinson disease and dementia with Lewy bodies. Eur Neuropsychopharmacol. 2021;46:52-53.
Midi I, Dogan M, Koseoglu M, Can G, Sehitoglu MA, Gunal DI. Voice abnormalities and their relation with motor dysfunction in Parkinson's disease. Acta Neurol Scand. 2008;117(1):26-34.
Ho AK, Iansek R, Marigliani C, Bradshaw JL, Gates S. Speech impairment in a large sample of patients with Parkinson's disease. Behav Neurol. 1999;11(3):131-137.
Lechien JR, Blecic S, Huet K, et al. Voice quality outcomes of idiopathic Parkinson's disease medical treatment: a systematic review. Clin Otolaryngol. 2018;43(3):882-903.
Pinto S, Ghio A, Teston B, Viallet F. Dysarthria across Parkinson's disease progression. Natural history of its components: dysphonia, dysprosody and dysarthria [in French]. Rev Neurol (Paris). 2010;166(10):800-810.
Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol. 2009;8(1):67-81.
Chiken S, Nambu A. Mechanism of deep brain stimulation. Neuroscientist. 2016;22(3):313-322.
Wyman-Chick KA. Verbal fluency in Parkinson's patients with and without bilateral deep brain stimulation of the subthalamic nucleus: a meta-analysis. J Int Neuropsychol Soc. 2016;22(4):478-485.
Thompson M, Tiwari A, Fu R, Moe E, Buckley DI. A Framework to Facilitate the Use of Systematic Reviews and Meta-Analyses in the Design of Primary Research Studies. Agency for Healthcare Research and Quality; 2012. Accessed December 27, 2021. http://www.ncbi.nlm.nih.gov/books/NBK83621/
McInnes MDF, Moher D, Thombs BD, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319(4):388-396.
Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. CHEST. 1989;95(2):2S-4S.
Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128(1):305-310.
Viswanathan M, Berkman ND, Dryden DM, Hartling L. Assessing Risk of Bias and Confounding in Observational Studies of Interventions or Exposures: Further Development of the RTI Item Bank. Agency for Healthcare Research and Quality; 2013. Accessed November 9, 2021. https://www.ncbi.nlm.nih.gov/books/NBK154463/
Tanaka Y, Tsuboi T, Watanabe H, et al. Voice features of Parkinson's disease patients with subthalamic nucleus deep brain stimulation. J Neurol. 2015;262(5):1173-1181.
Tsuboi T, Watanabe H, Tanaka Y, et al. Characteristic laryngoscopic findings in Parkinson's disease patients after subthalamic nucleus deep brain stimulation and its correlation with voice disorder. J Neural Transm (Vienna). 2015;122(12):1663-1672.
D'Alatri L, Paludetti G, Contarino MF, Galla S, Marchese MR, Bentivoglio AR. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment. J Voice. 2008;22(3):365-372.
Klostermann F, Ehlen F, Vesper J, et al. Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2008;79(5):522-529.
Törnqvist AL, Schalén L, Rehncrona S. Effects of different electrical parameter settings on the intelligibility of speech in patients with Parkinson's disease treated with subthalamic deep brain stimulation. Mov Disord. 2005;20(4):416-423.
Tripoliti E, Strong L, Hickey F, et al. Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease. Mov Disord. 2011;26(13):2434-2436.
Spielman J, Mahler L, Halpern A, Gilley P, Klepitskaya O, Ramig L. Intensive voice treatment (LSVT®LOUD) for Parkinson's disease following deep brain stimulation of the subthalamic nucleus. J Commun Disord. 2011;44(6):688-700.
Fabbri M, Zibetti M, Ferrero G, et al. Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria? Parkinsonism Relat Disord. 2019;64:242-248.
Morello ANDC, Beber BC, Fagundes VC, Cielo CA, Rieder CRM. Dysphonia and dysarthria in people with Parkinson's disease after subthalamic nucleus deep brain stimulation: effect of frequency modulation. J Voice. 2020;34(3):477-484.
Dayal V, Grover T, Tripoliti E, et al. Short versus conventional pulse-width deep brain stimulation in Parkinson's disease: a randomized crossover comparison. Mov Disord. 2020;35(1):101-108.
Zhang S, Zhou P, Jiang S, Wang W, Li P. Interleaving subthalamic nucleus deep brain stimulation to avoid side effects while achieving satisfactory motor benefits in Parkinson disease: a report of 12 cases. Medicine (Baltimore). 2016;95(49):e5575.
Piña-Fuentes D, van Dijk JMC, van Zijl JC, et al. Acute effects of adaptive deep brain stimulation in Parkinson's disease. Brain Stimul. 2020;13(6):1507-1516.
Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003;18(7):738-750.
Myrberg K, Hydén LC, Samuelsson C. The Mini-Mental State Examination (MMSE) from a language perspective: an analysis of test interaction. Clin Linguist Phon. 2020;34(7):652-670.
Cooper SE, McIntyre CC, Fernandez HH, Vitek JL. Association of deep brain stimulation washout effects with Parkinson disease duration. JAMA Neurol. 2013;70(1):95-99.
Tsuboi T, Watanabe H, Tanaka Y, et al. Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation. J Neurol Neurosurg Psychiatry. 2015;86(8):856-864.
Skodda S. Effect of deep brain stimulation on speech performance in Parkinson's disease. Parkinsons Dis. 2012;2012:850596.
Lu G, Luo L, Liu M, et al. Outcomes and adverse effects of deep brain stimulation on the ventral intermediate nucleus in patients with essential tremor. Neural Plast. 2020;2020:2486065.
Dietz J, Noecker AM, McIntyre CC, et al. Stimulation region within the globus pallidus does not affect verbal fluency performance. Brain Stimul. 2013;6(3):248-253.
Au KLK, Wong JK, Tsuboi T, et al. Globus pallidus internus (GPi) deep brain stimulation for Parkinson's disease: expert review and commentary. Neurol Ther. 2021;10(1):7-30.
Dashtipour K, Tafreshi A, Lee J, Crawley B. Speech disorders in Parkinson's disease: pathophysiology, medical management and surgical approaches. Neurodegener Dis Manag. 2018;8(5):337-348.
Brabenec L, Mekyska J, Galaz Z, Rektorova I. Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation. J Neural Transm (Vienna). 2017;124(3):303-334.
Vonberg I, Ehlen F, Fromm O, Kühn AA, Klostermann F. Deep brain stimulation of the subthalamic nucleus improves lexical switching in Parkinson's disease patients. PLoS One. 2016;11(8):e0161404.
Tanaka Y, Tsuboi T, Watanabe H, et al. Longitudinal speech change after subthalamic nucleus deep brain stimulation in Parkinson's disease patients: a 2-year prospective study. J Parkinsons Dis. 2020;10(1):131-140.
Tsuboi T, Watanabe H, Tanaka Y, et al. Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study. J Neural Transm (Vienna). 2017;124(12):1547-1556.
Lechien JR, Delsaut B, Abderrakib A, et al. Orofacial strength and voice quality as outcome of levodopa challenge test in Parkinson disease. Laryngoscope. 2020;130(12):E896-E903.
Miller N. Speech, voice and language in Parkinson's disease: changes and interventions. Neurodegenerative Dis Manage. 2012;2(3):279-289.
Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368-376.
Lechien JR, Huet K, Finck C, et al. Are the acoustic measurements reliable in the assessment of voice quality? A methodological prospective study. J Voice. 2021;35(2):203-215.
Fenoy AJ, McHenry MA, Schiess MC. Speech changes induced by deep brain stimulation of the subthalamic nucleus in Parkinson disease: involvement of the dentatorubrothalamic tract. J Neurosurg. 2017;126(6):2017-2027.
Ehlen F, Schoenecker T, Kühn AA, Klostermann F. Differential effects of deep brain stimulation on verbal fluency. Brain Lang. 2014;134:23-33.
Batens K, De Letter M, Raedt R, et al. Subthalamic nucleus stimulation and spontaneous language production in Parkinson's disease: a double laterality problem. Brain Lang. 2015;147:76-84.
Anzak A, Gaynor L, Beigi M, et al. A gamma band specific role of the subthalamic nucleus in switching during verbal fluency tasks in Parkinson's disease. Exp Neurol. 2011;232(2):136-142.
Ehlen F, Krugel LK, Vonberg I, Schoenecker T, Kühn AA, Klostermann F. Intact lexicon running slowly-prolonged response latencies in patients with subthalamic DBS and verbal fluency deficits. PLoS One. 2013;8(11):e79247.
Karl JA, Ouyang B, Verhagen Metman L. A novel dual-frequency deep brain stimulation paradigm for Parkinson's disease. Neurol Ther. 2019;8(2):483-489.
Keane M, Deyo S, Abosch A, Bajwa JA, Johnson MD. Improved spatial targeting with directionally segmented deep brain stimulation leads for treating essential tremor. J Neural Eng. 2012;9(4):046005.
Nguyen TAK, Djilas M, Nowacki A, et al. Analysis of patient-specific stimulation with segmented leads in the subthalamic nucleus. PLoS One. 2019;14(6):e0217985.
Pourfar MH, Mogilner AY. Lead angle matters: side effects of deep brain stimulation improved with adjustment of lead angle. Neuromodulation. 2016;19(8):877-881.
Pinto S, Ferraye M, Espesser R, et al. Stimulation of the pedunculopontine nucleus area in Parkinson's disease: effects on speech and intelligibility. Brain. 2014;137(pt 10):2759-2772.
Vos SH, Kessels RPC, Vinke RS, Esselink RAJ, Piai V. The effect of deep brain stimulation of the subthalamic nucleus on language function in Parkinson's disease: a systematic review. J Speech Lang Hear Res. 2021;64(7):2794-2810.
Leimbach F, Atkinson-Clement C, Wilkinson L, Cheung C, Jahanshahi M. Dissociable effects of subthalamic nucleus deep brain stimulation surgery and acute stimulation on verbal fluency in Parkinson's disease. Behav Brain Res. 2020;388:112621.
Behroozmand R, Johari K, Kelley RM, Kapnoula EC, Narayanan NS, Greenlee JDW. Effect of deep brain stimulation on vocal motor control mechanisms in Parkinson's disease. Parkinsonism Relat Disord. 2019;63:46-53.
Yilmaz A, Sarac ET, Aydinli FE, Yildizgoren MT, Okuyucu EE, Serarslan Y. Investigating the effect of STN-DBS stimulation and different frequency settings on the acoustic-articulatory features of vowels. Neurol Sci. 2018;39(10):1683-1689.
Martel-Sauvageau V, Tjaden K. Vocalic transitions as markers of speech acoustic changes with STN-DBS in Parkinson's disease. J Commun Disord. 2017;70:1-11.
Romann AJ, Beber BC, Olchik MR, Rieder CRM. Different outcomes of phonemic verbal fluency in Parkinson's disease patients with subthalamic nucleus deep brain stimulation. Arq Neuropsiquiatr. 2017;75(4):216-220.
Tanaka Y, Tsuboi T, Watanabe H, et al. Articulation features of Parkinson's disease patients with subthalamic nucleus deep brain stimulation. J Parkinsons Dis. 2016;6(4):811-819.
Eklund E, Qvist J, Sandström L, Viklund F, Van Doorn J, Karlsson F. Perceived articulatory precision in patients with Parkinson's disease after deep brain stimulation of subthalamic nucleus and caudal zona incerta. Clin Linguist Phon. 2015;29(2):150-166.
Krugel LK, Ehlen F, Tiedt HO, Kühn AA, Klostermann F. Differential impact of thalamic versus subthalamic deep brain stimulation on lexical processing. Neuropsychologia. 2014;63:175-184.
Marshall DF, Strutt AM, Williams AE, Simpson RK, Jankovic J, York MK. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Eur J Neurol. 2012;19(12):1525-1531.
Silveri MC, Ciccarelli N, Baldonero E, et al. Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease. Neuropsychologia. 2012;50(8):1980-1989.
Schulz GM, Hosey LA, Bradberry TJ, et al. Selective left, right and bilateral stimulation of subthalamic nuclei in Parkinson's disease: differential effects on motor, speech and language function. J Parkinsons Dis. 2012;2(1):29-40.
Xie Y, Zhang Y, Zheng Z, et al. Changes in speech characters of patients with Parkinson's disease after bilateral subthalamic nucleus stimulation. J Voice. 2011;25(6):751-758.
Van Lancker Sidtis D, Rogers T, Godier V, Tagliati M, Sidtis JJ. Voice and fluency changes as a function of speech task and deep brain stimulation. J Speech Lang Hear Res. 2010;53(5):1167-1177.
Lee VS, Zhou XP, Rahn DA, Wang EQ, Jiang JJ. Perturbation and nonlinear dynamic analysis of acoustic phonatory signal in Parkinsonian patients receiving deep brain stimulation. J Commun Disord. 2008;41(6):485-500.
Dromey C, Kumar R, Lang AE, Lozano AM. An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Mov Disord. 2000;15(6):1132-1138.
Chiu SY, Tsuboi T, Hegland KW, et al. Dysarthria and speech intelligibility following Parkinson's disease globus pallidus internus deep brain stimulation. J Parkinsons Dis. 2020;10(4):1493-1502.
Sandström L, Hägglund P, Johansson L, Blomstedt P, Karlsson F. Speech intelligibility in Parkinson's disease patients with zona incerta deep brain stimulation. Brain Behav. 2015;5(10):e00394.
Aström M, Tripoliti E, Hariz MI, et al. Patient-specific model-based investigation of speech intelligibility and movement during deep brain stimulation. Stereotact Funct Neurosurg. 2010;88(4):224-233.
Fabbri M, Natale F, Artusi CA, et al. Deep brain stimulation fine-tuning in Parkinson's disease: short pulse width effect on speech. Parkinsonism Relat Disord. 2021;87:130-134.
Little S, Tripoliti E, Beudel M, et al. Adaptive deep brain stimulation for Parkinson's disease demonstrates reduced speech side effects compared to conventional stimulation in the acute setting. J Neurol Neurosurg Psychiatry. 2016;87(12):1388-1389.